Kiromic Biopharma, Inc. Operating Cash Flow
Kiromic Biopharma, Inc. reported Operating Cash Flow of -$19.46 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-02-14
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$3.65M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$1.93M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$8.18M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$5.70M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$19.46M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$21.23M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$23.75M.
- Kiromic Biopharma, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$20.32M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$5.58M derived: sum of 2 quarters · filed 2025-02-14 | -$13.76M derived: sum of 3 quarters · filed 2025-02-14 | -$19.46M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$10.11M derived: sum of 2 quarters · filed 2024-11-08 | -$15.81M 10-Q · filed 2024-11-08 | -$21.22M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | -$8.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$13.88M 10-Q · filed 2024-08-09 | -$19.29M derived: sum of 3 quarters · filed 2025-02-14 | -$24.52M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | -$5.70M 10-Q · filed 2024-05-10 | -$11.11M derived: sum of 2 quarters · filed 2025-02-14 | -$16.34M derived: sum of 3 quarters · filed 2025-02-14 | -$22.80M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | -$5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$10.64M derived: sum of 2 quarters · filed 2025-02-14 | -$17.10M derived: sum of 3 quarters · filed 2025-02-14 | -$21.23M 10-K · filed 2025-02-14 | -$21.23M 10-K · filed 2024-03-19 | |||
| 2023-09-30 | -$5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$11.69M derived: sum of 2 quarters · filed 2024-11-08 | -$15.82M 10-Q · filed 2024-11-08 | -$15.82M 10-Q · filed 2023-11-14 | -$19.92M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | -$6.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$10.59M 10-Q · filed 2024-08-09 | -$10.59M 10-Q · filed 2023-08-14 | -$14.69M derived: sum of 3 quarters · filed 2024-08-09 | -$20.79M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$4.13M 10-Q · filed 2024-05-10 | -$4.13M 10-Q · filed 2023-05-15 | -$8.23M derived: sum of 2 quarters · filed 2024-05-10 | -$14.33M derived: sum of 3 quarters · filed 2024-05-10 | -$20.30M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$10.20M derived: sum of 2 quarters · filed 2024-03-19 | -$16.17M derived: sum of 3 quarters · filed 2024-03-19 | -$23.75M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$12.06M derived: sum of 2 quarters · filed 2023-11-14 | -$19.64M 10-Q · filed 2023-11-14 | -$28.81M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.55M 10-Q · filed 2023-08-14 | -$22.71M derived: sum of 3 quarters · filed 2023-08-14 | -$27.53M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$7.58M 10-Q · filed 2023-05-15 | -$16.74M derived: sum of 2 quarters · filed 2023-05-15 | -$21.56M derived: sum of 3 quarters · filed 2023-05-15 | -$25.26M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$9.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$13.98M derived: sum of 2 quarters · filed 2023-04-17 | -$17.69M derived: sum of 3 quarters · filed 2023-04-17 | -$20.32M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | -$4.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.52M derived: sum of 2 quarters · filed 2022-11-14 | -$11.16M 10-Q · filed 2022-11-14 | -$13.73M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$6.34M 10-Q · filed 2022-08-12 | -$8.91M derived: sum of 3 quarters · filed 2022-08-12 | -$9.87M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$2.64M 10-Q · filed 2022-05-13 | -$5.21M derived: sum of 2 quarters · filed 2022-05-13 | -$6.16M derived: sum of 3 quarters · filed 2022-05-13 | -$7.28M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$3.52M derived: sum of 2 quarters · filed 2022-04-08 | -$4.65M derived: sum of 3 quarters · filed 2022-04-08 | -$6.13M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | -$953.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-11 | -$2.08M derived: sum of 2 quarters · filed 2022-03-11 | -$3.56M 10-Q · filed 2022-03-11 | -$5.47M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$2.60M 10-Q · filed 2021-08-13 | -$4.52M derived: sum of 3 quarters · filed 2021-08-13 | |||||
| 2020-03-31 | -$1.48M 10-Q · filed 2021-05-14 | -$3.39M derived: sum of 2 quarters · filed 2021-05-14 | ||||||
| 2019-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$2.91M 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | -$1.00M 10-Q · filed 2020-11-30 |